Gender Transition: Embracing Change, Navigating Challenges
Western European countries generally adopt a progressive stance towards gender transition, exemplified by streamlined legal procedures for gender recognition in nations like the Netherlands and Denmark, where hormone therapy plays a pivotal role. However, Eastern European regions often exhibit more conservative perspectives. Social stigma and limited access to specialised healthcare can impede transgender individuals' access to HT in these areas.
Menopause: Balancing Risks and Benefits
The use of HT for managing menopausal symptoms in Europe reflects a cautious optimism. Following the Women's Health Initiative study's findings, which raised concerns about potential health risks associated with HT, there was a decline in its usage. Nevertheless, recent research underscores a nuanced understanding, considering factors such as dosage and individual health status. European countries are witnessing a cautious resurgence in HT use, often favouring bioidentical hormones that mimic the body's natural hormonal balance.
Addressing Diverse Healthcare Needs
HT extends beyond gender transition and menopause to treat various hormone-related conditions like hypothyroidism, sex hormone deficiencies, and specific cancers. Cultural perspectives significantly influence treatment choices, with some regions incorporating traditional medicine practices alongside or instead of HT. Moreover, concerns regarding synthetic hormones may contribute to treatment hesitancy among patients.
